title: P2 receptor agonists stimulate insulin release from human pancreatic islets.
abstract: Although P2 receptors for adenosine 5'-triphosphate (ATP) and/or adenosine 5'-diphosphate (ADP) have been characterized in mammalian pancreatic beta cells, no evidence for an insulin-secreting effect of P2 receptor agonists has been reported as yet in humans. The present study aimed at investigating whether P2 receptor agonists could stimulate insulin release in human pancreatic islets obtained from brain-dead organ donors. Experiments were performed using different glucose concentrations and insulin was measured by radioimmunoassay. When the glucose concentration (8.3 mmol/L) was slightly stimulating for insulin release, alpha,beta-methylene ATP (200 micromol/L) and ADPbetaS (50 micromol/L) similarly amplified insulin secretion: both compounds induced a threefold increase in insulin response. In the presence of a nonstimulating glucose concentration (3.0 mmol/L), only alpha,beta-methylene ATP could induce a significant 1.4-fold increase in insulin release, ADPbetaS being completely ineffective. These results give evidence that P2 receptor agonists are effective in stimulating insulin release in humans, the effect of the P2Y agonist being essentially glucose dependent.
authors.affiliation: Endocrinology and Diabetes Unit, Hospital Clinic i Universitari, Barcelona, Spain.
authors.forename: J
authors.initials: J
authors.lastname: Fernandez-Alvarez
authors.forename: D
authors.initials: D
authors.lastname: Hillaire-Buys
authors.forename: M M
authors.initials: MM
authors.lastname: Loubatières-Mariani
authors.forename: R
authors.initials: R
authors.lastname: Gomis
authors.forename: P
authors.initials: P
authors.lastname: Petit
mesh_terms: D000244:Adenosine Diphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000255:Adenosine Triphosphate / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000328:Adult; D005947:Glucose / Q000494:pharmacology; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D058910:Purinergic P2 Receptor Agonists; D011863:Radioimmunoassay; D058469:Receptors, Purinergic P2X; D058472:Receptors, Purinergic P2Y1; D013873:Thionucleotides / Q000494:pharmacology*
chemical_list: D007328:Insulin; C546382:P2RY1 protein, human; D058910:Purinergic P2 Receptor Agonists; D058469:Receptors, Purinergic P2X; D058472:Receptors, Purinergic P2Y1; D013873:Thionucleotides; C030812:adenosine 5'-O-(2-thiodiphosphate); D000244:Adenosine Diphosphate; D000255:Adenosine Triphosphate; D005947:Glucose; C002630:alpha,beta-methyleneadenosine 5'-triphosphate